DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak
Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. coli strains.
The data obtained from the DNA sequencer shows the presence of genes typically found in two different types of E. coli: enteroaggregative E. coli (EAEC) and enterohemorrhagic E. coli (EHEC). These results, which are being confirmed by further data analysis on the Ion PGM™, may provide insight into this bacterium's aggressiveness and help prevent further outbreaks.
"The rapid whole genome sequencing results enabled us to discover within days a unique combination of virulence traits ... and makes this German outbreak clone a unique hybrid of different E. coli pathovars," said Dr. med. Alexander Mellmann, scientist at the German National Consulting Laboratory for Hemolytic Uremic Syndrome (HUS) at the Institute of Hygiene, University Hospital Muenster.
The data gathered at Life Technologies' laboratories in Darmstadt, Germany, will be used by scientists at the University Hospital Muenster, to develop better tests to positively identify the illness in people showing symptoms of the infection, which includes kidney failure and bloody diarrhea. For the first time since the outbreak, it is now possible to study in detail the basis for what makes this strain so aggressive.
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

A novel antibiotic from weeds
Towards a new moth perfume
Discovery of 100 million-year-old regions of DNA shows short cut to crop science advances

Click... Resistant bacteria caught in the act! - Scientists have succeeded in capturing unique images of protein soldiers that help bacteria resist drugs
Hesperion announces the opening of its Russian Moscow Office

Takara Bio and Eppendorf cooperate - Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency
New genetic links to MS also play roles in other autoimmune diseases

Dust mite allergens trigger inflammatory responses - Dust mite allergens activate the pulmonary immune system, thereby triggering allergies
